{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:47:00Z","timestamp":1788871620793,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"FDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"FDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.vaccine.2014.09.049","type":"journal-article","created":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T07:34:40Z","timestamp":1412408080000},"page":"6421-6432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["H5 N-terminal \u03b2 sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Surender","family":"Khurana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Manischewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey J.","family":"Crevar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.09.049_bib0005","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/j.vaccine.2011.06.014","article-title":"Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines","volume":"29","author":"Khurana","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0010","doi-asserted-by":"crossref","first-page":"e11548","DOI":"10.1371\/journal.pone.0011548","article-title":"Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus","volume":"5","author":"Khurana","year":"2010","journal-title":"PLoS ONE."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0015","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1128\/JVI.02107-10","article-title":"Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets","volume":"85","author":"Khurana","year":"2010","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0020","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1128\/JVI.01596-12","article-title":"Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies","volume":"86","author":"Verma","year":"2012","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0025","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.1239844","article-title":"Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs","volume":"341","author":"Zhu","year":"2013","journal-title":"Science."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature12392","article-title":"Characterization of H7N9 influenza A viruses isolated from humans","volume":"501","author":"Watanabe","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1304617","article-title":"Epidemiology of human infections with avian influenza A(H7N9) virus in China","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0045","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.vaccine.2013.07.043","article-title":"Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A\/Anhui\/1\/2013 (H7N9) protection and heterologous A\/chicken\/Jalisco\/CPA1\/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus","volume":"31","author":"Smith","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0050","doi-asserted-by":"crossref","first-page":"185ra68","DOI":"10.1126\/scitranslmed.3006368","article-title":"Synthetic generation of influenza vaccine viruses for rapid response to pandemics","volume":"5","author":"Dormitzer","year":"2013","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0055","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0060","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jir791","article-title":"Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender","volume":"205","author":"Khurana","year":"2011","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tvjl.2007.07.004","article-title":"Avian influenza: We have the chance to make a difference","volume":"174","author":"Capua","year":"2007","journal-title":"Vet J."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(04)15589-X","article-title":"Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands","volume":"363","author":"Koopmans","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0075","doi-asserted-by":"crossref","first-page":"e49704","DOI":"10.1371\/journal.pone.0049704","article-title":"A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine","volume":"7","author":"Couch","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1126\/science.1240532","article-title":"H7N9 influenza viruses are transmissible in ferrets by respiratory droplet","volume":"341","author":"Zhang","year":"2013","journal-title":"Science."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0085","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1086\/651663","article-title":"High probability of avian influenza virus (H7N7) transmission from poultry to humans active in disease control on infected farms","volume":"201","author":"Bos","year":"2010","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0090","doi-asserted-by":"crossref","first-page":"8645","DOI":"10.1128\/JVI.00281-12","article-title":"Structure and receptor complexes of the hemagglutinin from a highly pathogenic H7N7 influenza virus","volume":"86","author":"Yang","year":"2012","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0095","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1128\/JVI.00187-08","article-title":"Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus","volume":"82","author":"Wei","year":"2008","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2014.09.049_bib0100","first-page":"2009","article-title":"Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin","author":"Weldon","year":"2009","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14013176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14013176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T16:50:48Z","timestamp":1538153448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14013176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":20,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0264410X14013176"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H5 N-terminal \u03b2 sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}